Navigation Links
New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes
Date:4/29/2009

term outcomes. Drug exposure was measured as the medication possession ratio (MPR) defined as the actual time the patient received therapy divided by the total time possible before a negative outcome was reached (or at data censor). A statistical method called recursive partitioning was then used to divide treatment groups into "high" or "low" exposure and to determine the relationship between length of drug exposure and long-term outcomes. The use of MPR reduces the bias introduced in long-term trials by the tendency of patients who are doing well on therapy stay on therapy and for patients who are doing poorly to stop a particular therapy. Other statistical approaches including Propensity Scoring were used to control for other known sources of bias.(1) The study, sponsored by Bayer HealthCare Pharmaceuticals, is the longest follow-up of a registrational MS trial cohort. Longitudinal data from 372 patients, collected 16 years after the start of the registrational trial, were used to develop an analytical strategy to investigate the relationship between timing of drug initiation and exposure and long-term outcomes.

INDICATIONS AND USAGE

BETASERON (interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.

IMPORTANT SAFETY INFORMATION

The most commonly reported adverse reactions are lymphopenia, injection-site reaction, asthenia, flu-like symptom complex, headache and pain. Gradual dose titration and use of analgesics during treatment initiation may help reduce flu-like symptoms. BETASERON should be used with caution in patients with depression. Injection-site necrosis has been reported in 4% o
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Innerscope Research(TM) Names Caleb Siefert as Senior Scientist to Lead Companys Statistical Analyses and Study Designs
2. Tissue analyses indicate survival benefits for some lung cancer patients
3. New Analyses Confirm Nexavars Efficacy and Safety in Multiple Patient Subsets With Liver Cancer
4. Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
5. New Analyses of long-term LIALDA (mesalamine) data presented at ACG
6. 16-Year-Old Ecuadorian Boy in Dire Need of Dialysis Treatments Thanks One of Nations Leading Providers for Saving His Life
7. Facet Solutions Completes 1 Year Follow-up on U.S. Pilot Study
8. Siemens Highlights Cardiology Excellence from Prevention to Follow-up at ACC 2009
9. Follow-Up Tests of Leading Personal Care and Household Cleaning Brands Reveal Improvements in Levels of Carcinogenic 1,4-dioxane
10. Follow-Up Tests of Leading Personal Care and Household Cleaning Brands Reveal Significant Improvements in Levels of Carcinogenic 1,4-dioxane
11. National Coalition for Cancer Survivorship, UCLA, WellPoint, and Genentech Launch Initiative to Provide Coordinated Follow-Up Care for People Surviving Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... FL (PRWEB) July 28, 2014 Termed ... prescription drug abuse causes more fatal overdoses than heroin ... a year. (1) Those who are particularly vulnerable to ... age and up), with many in this age group ... regarding this growing epidemic was reawakened in the White ...
(Date:7/28/2014)... has released a new blog post presenting ... Comparing life insurance quotes can help clients save up ... coverage is easier online by visiting insurance brokerage websites. ... them on a single web page. , By ... but they can also learn more about life insurance. ...
(Date:7/28/2014)... Thompson HealthDay Reporter FRIDAY, July ... 30-year policy that bans blood donations from gay and bisexual men, ... week in the Journal of the American Medical Association . ... man cannot donate blood in the United States -- a lifetime ... Food and Drug Administration adopted this policy at the dawn of ...
(Date:7/28/2014)... HealthDay Reporter FRIDAY, July ... on contraception coverage -- as mandated under the Affordable Care ... allow companies to deny insurance coverage for any medical practice ... But other experts counter that such predictions are unlikely ... that Hobby Lobby Stores Inc. and Conestoga Wood Specialties Corp. ...
(Date:7/28/2014)... For those with dust allergies, home can be ... settle in mattresses, bedding, and upholstered furniture and elicit allergic ... microscopic insects that feed on the dead skin of pets ... a million dust mites fat and happy. When a speck ... decaying bodies and feces of dust mites can be seen.  ...
Breaking Medicine News(10 mins):Health News:Rx Drug Abuse Labeled Silent Killer: Claims Nearly 17,000 American Lives a Year; Novus Medical Detox Solution Involves Education and Governmental Support 2Health News:Rx Drug Abuse Labeled Silent Killer: Claims Nearly 17,000 American Lives a Year; Novus Medical Detox Solution Involves Education and Governmental Support 3Health News:Rx Drug Abuse Labeled Silent Killer: Claims Nearly 17,000 American Lives a Year; Novus Medical Detox Solution Involves Education and Governmental Support 4Health News:Comparing Life Insurance Quotes Online Offers 3 Important Advantages! 2Health News:Lift U.S. Ban on Blood Donations by Gay Men, Experts Say 2Health News:Lift U.S. Ban on Blood Donations by Gay Men, Experts Say 3Health News:The 'Hobby Lobby Ruling' and What It Means for U.S. Health Care 2Health News:The 'Hobby Lobby Ruling' and What It Means for U.S. Health Care 3Health News:The 'Hobby Lobby Ruling' and What It Means for U.S. Health Care 4Health News:The 'Hobby Lobby Ruling' and What It Means for U.S. Health Care 5Health News:AllergyEasy® Announces No-shots Immunotherapy to Mitigate Dust Allergies 2Health News:AllergyEasy® Announces No-shots Immunotherapy to Mitigate Dust Allergies 3
... is often on those already on drugs, some diagnoses ... (HealthDay News) -- A new study questions the commonly ... ) infections are always preceded by antibiotic use. , ... found that slightly more than half of senior citizens ...
... Wis., Oct. 10 More than 600 new Wisconsin,voters ... the,result of Aurora Health Care,s voter registration drives held ... system,s 13 hospitals across Eastern,Wisconsin. A total of 658 ... Aurora employees and volunteers, who were trained by the ...
... , ... Boston (Vocus) October 10, 2008 -- Several pediatric ... at the 2008 American Academy of Pediatrics National Conference and Exhibition, ... topics are listed below. , , Pediatrician Dana Best, ...
... Up with Legal and Medical Panel to Offer,Real-Life ... in,Knoxville, KNOXVILLE, Tenn., Oct. 10 In ... Careers and its founding partner,Roche have joined forces ... cancer advocate Holly Warlick, University of Tennessee,women,s basketball ...
... Honoring excellence in the implementation of electronic health records (EHRs), ... recipients of the 2008 Davies Awards in the Organizational, Ambulatory ... ... Chicago, IL (PRWEB) October 10, 2008 -- Honoring excellence ...
... Oct. 10 Accuray,Incorporated (Nasdaq: ARAY ), a ... it will report results for its first quarter fiscal,year ... 2008 after,the market closes., A conference call to ... p.m. EDT) and will be hosted by Euan S. ...
Cached Medicine News:Health News:Antibiotics May Not Cause Diarrheal Bacteria 2Health News:Children's National Experts Presenting at American Academy of Pediatrics Conference 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Accuray Incorporated to Report First Quarter Fiscal Year 2009 Financial Results 2
(Date:7/25/2014)... Calif. , July 25, 2014  Depomed, Inc. ... will release second quarter fiscal year 2014 financial results ... Company will host a conference call beginning at 4:30 ... Participants can access the call by dialing 877-317-6789 ( ... conference call will also be available via a live ...
(Date:7/25/2014)... July 25, 2014  CVS Caremark Corporation (NYSE: ... on Tuesday, August 5, 2014, at 8:30 a.m. (EDT) ... 2014 financial results. An audio webcast of ... Investor Relations portion of the CVS Caremark website for ... http://info.cvscaremark.com/investors . This webcast will be archived and available ...
(Date:7/25/2014)... 2014  Acsis Inc., the market leader for ... has recently posted an article, "Future of ... future needs for companies, extended supply chain, and ... model no longer work today.  The article explains ... of mobile technology, machine to machine (M2M) connectivity, ...
Breaking Medicine Technology:Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 2Acsis Addresses Questions on the Modern Supply Chain 2
... There are some two dozen oncology therapies in Phase ... development. While only some of these therapies will make it ... a competitive marketplace where success revolves around planning as much ... in the oncology therapeutic area must constantly evaluate which factors ...
... April 20, 2012 A recent clinical trial conducted at ... drug used to treat Parkinson,s Disease greatly improves the quality ... such as tremors, slowness, stiffness and difficulty walking. ... hold the trial, which was led by Dr. C. Warren ...
Cached Medicine Technology:Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector 2Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinson's Disease 2Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinson's Disease 3
Spectra Plus has been specifically designed as a compact, lightweight and portable indirect with big benefits for professionals on the move. It can be tucked away in its neat carrying case or hung ar...
Wampole Rubella-plus is an immunochromatographic assay for the qualitative detection of Rubella antibody (IgG) in human serum or plasma....
NOW Streptococcus pneumoniae is a rapid immunochromatographic assay for the detection of ,S. pneumoniae antigen in the urine of patients with pneumonia and in the cerebral spinal fluid of patients ...
Clearview RSV is a simple, immunochromatographic assay to aid in the diagnosis of respiratory syncytial virus (RSV) infections in children less than 6 years and adults over age 60....
Medicine Products: